Q. Yue

发表

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

P. Arlett, L. Henderson, Q. Yue, 2002, British journal of clinical pharmacology.

Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival

C. Wadelius, N. Eriksson, P. Magnusson, 2019, EBioMedicine.

Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilance

K. Blake, P. Arlett, Q. Yue, 2016, Pharmacoepidemiology and drug safety.

Montelukast and Nightmares: Further Characterisation Using Data from VigiBase

H. Taavola, Sarah Watson, Q. Yue, 2022, Drug Safety.

Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria

Q. Yue, P. Caduff-Janosa, 2022, Drugs - Real World Outcomes.

Safety of St John's wort (Hypericum perforatum)

Q. Yue, C. Bergquist, B. Gerdén, 2000, The Lancet.

The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance

Q. Yue, 2021, Drug Safety.

Hypericum perforatum ): drug interactions and clinical outcomes

Q. Yue, C. Bergquist, B. Gerdén, 2002 .

Herbal Drug Curbicin and Anticoagulation Effect with and without Warfarin: Possibly Related to the Vitamin E Component

Q. Yue, Kerstin Jansson, 2001 .

Risk Factors for Extrapyramidal Symptoms During Treatment With Selective Serotonin Reuptake Inhibitors, Including Cytochrome P-450 Enzyme, and Serotonin and Dopamine Transporter and Receptor Polymorphisms

O. Spigset, K. Hedenmalm, M. Dahl, 2006, Journal of clinical psychopharmacology.

Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase

Suying Yan, Q. Yue, Qian-wen Ding, 2022, European Journal of Clinical Pharmacology.

Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge

H. Taavola, J. Barrett, Q. Yue, 2022, Therapeutic advances in drug safety.

Orlistat associated with hypertension

S. Vitols, Q. Yue, Matty Persson, 2000, BMJ : British Medical Journal.

Fusidic Acid: A Neglected Risk Factor for Statin-Associated Myopathy

P. Hallberg, M. Wadelius, Q. Yue, 2018, Clinical Medicine Insights. Cardiology.

Tumor necrosis factor inhibitor-induced pleuropericarditis: A retrospective evaluation using data from VigiBase.

Q. Yue, Qingxia Zhang, 2020, International immunopharmacology.

Appendicitis as a possible safety signal for the COVID-19 vaccines

Q. Yue, Joseph C. Mitchell, 2021, Vaccine: X.

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.

M. Daly, D. Goldstein, M. Nelson, 2011, Gastroenterology.

Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population.

N. Eriksson, M. Molokhia, P. Magnusson, 2016, The lancet. Diabetes & endocrinology.

Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population.

C. Wadelius, N. Eriksson, P. Magnusson, 2017, Pharmacogenomics.

Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment

C. Wadelius, N. Eriksson, A. Syvänen, 2020, The Pharmacogenomics Journal.

Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBase

Suying Yan, Q. Yue, Qian-wen Ding, 2021, Frontiers in Pharmacology.

Sulfasalazine‐Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus

N. Eriksson, M. Molokhia, P. Magnusson, 2017, Clinical pharmacology and therapeutics.

Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker–Induced Angioedema

N. Eriksson, A. Syvänen, P. Magnusson, 2020, Clinical pharmacology and therapeutics.

SWEDEGENE—a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions

H. Melhus, P. Hallberg, M. Wadelius, 2020, The Pharmacogenomics Journal.

Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population

M. Ingelman-Sundberg, M. Lang, O. Pelkonen, 1999, FEBS letters.

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase

A. Lillo-Le Louet, D. Smadja, R. Chocron, 2021, European Respiratory Journal.

Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing

A. Morris, R. Gibbs, E. Boerwinkle, 2019, PloS one.

A common missense variant of LILRB5 is associated with statin intolerance and myalgia

P. Ridker, D. Chasman, M. Pirmohamed, 2017, European heart journal.

ALENDRONATE — RISK FOR ESOPHAGEAL STRICTURE

Q. Yue, Q. Yue, O. Mortimer, 1998, Journal of the American Geriatrics Society.

SWEDEGENE—a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions

H. Melhus, P. Hallberg, M. Wadelius, 2020, The Pharmacogenomics Journal.

Fusidic Acid: A Neglected Risk Factor for Statin-Associated Myopathy

P. Hallberg, M. Wadelius, Q. Yue, 2018 .

Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors

O. Wallerman, C. Wadelius, H. Melhus, 2004, The Pharmacogenomics Journal.

Comparison of Clinical Factors Between Patients With Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema and Cough

P. Hallberg, M. Wadelius, Hans-Erik Johansson, 2017, The Annals of pharmacotherapy.

Genome-Wide Association Study of Angioedema Induced by Ace Inhibitors or Arbs in Sweden

N. Eriksson, P. Magnusson, P. Hallberg, 2017 .

Clinical factors predicting drug-induced liver injury due to flucloxacillin

P. Hallberg, M. Wadelius, Q. Yue, 2018, Drug, healthcare and patient safety.